Your session is about to expire
← Back to Search
Virtual Program for Smoking Cessation
N/A
Recruiting
Led By Jean Wong, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-reported smokers who have smoked cigarettes within the past 30 days
18+ years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up surgery: (i)day of recruitment, (ii)day of surgery, (iii) 7 day follow-up, (iv) 30 day follow-up; fracture clinic: (i)day of recruitment, (ii)7 day follow-up, (iii) 14 day follow-up, (iv) 30 day follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a virtual smoking cessation program to see if it's an effective way to help people quit smoking and reduce risks before surgery. #stopsmoking #smokefree
Who is the study for?
This trial is for adults over 18 who smoke cigarettes, whether daily or occasionally. They must be scheduled for elective surgery in at least 48 hours or visiting a fracture clinic within 14 days of injury/surgery and have an email address. It's not suitable for those who don't meet these criteria.
What is being tested?
The study tests a virtual smoking cessation program against standard care to see if it helps people quit smoking before/after surgery or with bone fractures. It includes e-learning about smoking risks and tailored emails based on nicotine dependence and motivation to quit.
What are the potential side effects?
Since this is a non-medical intervention focusing on education and support through email, there are no direct side effects like you'd expect from medication. However, participants may experience usual nicotine withdrawal symptoms when trying to quit.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have smoked cigarettes in the last 30 days.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ surgery: (i)day of recruitment, (ii)day of surgery, (iii) 7 day follow-up, (iv) 30 day follow-up; fracture clinic: (i)day of recruitment, (ii)7 day follow-up, (iii) 14 day follow-up, (iv) 30 day follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~surgery: (i)day of recruitment, (ii)day of surgery, (iii) 7 day follow-up, (iv) 30 day follow-up; fracture clinic: (i)day of recruitment, (ii)7 day follow-up, (iii) 14 day follow-up, (iv) 30 day follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Trial feasibility - Acceptability of e-learning module program component
Trial feasibility - Acceptability of the email message program component
Trial feasibility - EPIC patient portal usage
+2 moreSecondary study objectives
Smoke
Complications/Adverse Events
Module Education
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Arm: Virtual GroupExperimental Treatment1 Intervention
The intervention will involve participating in the study's virtual smoking cessation program. This program consists of 2 components: an e-learning module and a tailored email messaging program based on the participant's motivation to quit smoking and their Fagerstrom test for nicotine dependence score.
Group II: Control Arm: Standard CareActive Control1 Intervention
This arm will receive standard care which may or may not include brief advice to quit smoking from any of the healthcare providers.
Providing smoking cessation intervention is not mandatory in standard care and may not be provided.
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,526 Previous Clinical Trials
503,146 Total Patients Enrolled
Jean Wong, MDPrincipal InvestigatorUniversity Health Network, Toronto
6 Previous Clinical Trials
580 Total Patients Enrolled